Catalyst Wire Dossier Catalyst Wire Dossier

Striverdi

olodaterol · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Striverdi, covering 2015-07-16 to 2015-07-16. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Effect on Lung Function and ECG When a Combination of Tiotropium Plus Olodaterol is Administered to Patients With COPD Either From a Single Inhaler or Each Compound is Administered After Each Other From Two Different Inhalers [Phase 2]

See pricing